Indivior PLC - Ordinary Shares

Indivior PLC - Ordinary Shares Stock Forecast & Price Prediction

Live Indivior PLC - Ordinary Shares Stock (INDV) Price
$9.30

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$9.30

P/E Ratio

272.00

Volume Traded Today

$1.2M

Dividend

Dividends not available for INDV

52 Week High/low

23.22/7.33

Indivior PLC - Ordinary Shares Market Cap

$1.18B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $INDV ๐Ÿ›‘

Before you buy INDV you'll want to see this list of ten stocks that have huge potential. Want to see if INDV made the cut? Enter your email below

INDV Summary

The Indivior PLC - Ordinary Shares (INDV) share price is expected to increase by 72.04% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered INDV. Price targets range from $16 at the low end to $16 at the high end. The current analyst consensus for INDV is a sell. Please note analyst price targets are not guaranteed and could be missed completely.

INDV Analyst Ratings

About 0 Wall Street analysts have assignedINDV 0 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Indivior PLC - Ordinary Shares to sell. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on INDV. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

INDV stock forecast by analyst

These are the latest 20 analyst ratings of INDV.

Analyst/Firm

Rating

Price Target

Change

Date

David Amsellem
Piper Sandler

Overweight

$16

Reiterates

Oct 25, 2024
Chase Knickerbocker
Craig-Hallum

Buy

$16

Maintains

Oct 11, 2024
David Amsellem
Piper Sandler

Overweight

$15

Reiterates

Oct 11, 2024
David Amsellem
Piper Sandler

Overweight

$22

Reiterates

Sep 13, 2024
David Amsellem
Piper Sandler

Overweight

$22

Initiates

Jul 23, 2024
Chase Knickerbocker
Craig-Hallum

Buy

$24

Maintains

Jul 10, 2024
Chase Knickerbocker
Craig-Hallum

Buy

$37

Initiates

Apr 3, 2024

INDV Company Information

What They Do: Develops prescription drugs for opioid dependence.

Business Model: The company generates revenue through the development, manufacture, and sale of buprenorphine-based pharmaceuticals aimed at treating opioid dependence and related disorders. Its key products include SUBLOCADE, SUBOXONE, and OPVEE, which are sold in multiple markets, including the U.S. and the U.K. Additionally, it is involved in various partnerships to develop new therapies for substance use disorders.

Other Information: Indivior is actively engaged in research and development, with several products in clinical trials and pre-clinical stages. The company also collaborates with other firms like ADDEX therapeutics and Alar Pharmaceuticals to innovate treatments for alcohol use disorder and opioid use disorder. Established in 2014, it is headquartered in North Chesterfield, Virginia.
INDV
Indivior PLC - Ordinary Shares (INDV)

When did it IPO

2014

Staff Count

1,000

Country

United States

Sector/Industry

Healthcare/Drug Manufacturersโ€”Specialty & Generic

CEO

Mr. Mark Crossley

Market Cap

$1.18B

Indivior PLC - Ordinary Shares (INDV) Financial Data

In 2023, INDV generated $1.09B in revenue, which was a increase of 21.31% from the previous year. This can be seen as a signal that INDV's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$647.0M

Revenue From 2021

$791.0M

22.26 %
From Previous Year

Revenue From 2022

$901.0M

13.91 %
From Previous Year

Revenue From 2023

$1.09B

21.31 %
From Previous Year
  • Revenue TTM $1.18B
  • Operating Margin TTM 30.6%
  • Gross profit TTM $907.0M
  • Return on assets TTM 11.3%
  • Return on equity TTM 0.0%
  • Profit Margin -0.3%
  • Book Value Per Share -1.29%
  • Market capitalisation $1.18B
  • Revenue for 2021 $791.0M
  • Revenue for 2022 $901.0M
  • Revenue for 2023 $1.09B
  • EPS this year (TTM) $-0.03

Indivior PLC - Ordinary Shares (INDV) Latest News

News Image

Wed, 30 Oct 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Indivior PLC highlighted key findings on the effectiveness of SUBLOCADEยฎ for treating opioid use disorder, emphasizing improvements in abstinence and recovery outcomes.

Why It Matters - Indivior's update on SUBLOCADE's effectiveness strengthens its market position in opioid treatment, potentially boosting sales and investor confidence in its growth prospects.

News Image

Thu, 24 Oct 2024

Sentiment - NEUTRAL

Source - Proactive Investors

Summary - Indivior PLC maintains its full-year outlook despite recent profit warnings. In Q3 results, it noted short-term challenges but reassured investors about long-term prospects amid competition.

Why It Matters - Indivior's maintained outlook amid recent profit warnings signals potential stability, but increased competition from Brixadi poses risks to market share and future earnings.

News Image

Thu, 24 Oct 2024

Sentiment - POSITIVE

Source - Proactive Investors

Summary - Indivior PLC shares rose 11% after reaffirming its full-year outlook. Q3 revenue increased 13% to $307M, with Sublocade sales up 14% to $191M despite competition.

Why It Matters - Indivior's strong revenue growth and reaffirmed outlook amid competition boost investor confidence, signaling resilience and potential for continued profitability in the opioid treatment market.

News Image

Thu, 24 Oct 2024

Sentiment - NEUTRAL

Source - Seeking Alpha

Summary - Indivior PLC (NASDAQ:INDV) will host its Q3 2024 earnings conference call on October 24, 2024, at 8:00 AM ET, featuring key executives and analysts.

Why It Matters - The Q3 2024 earnings call for Indivior PLC will provide insights into the company's financial health and strategic direction, impacting stock performance and investor sentiment.

News Image

Thu, 24 Oct 2024

Sentiment - NEUTRAL

Source - PRNewsWire

Summary - Indivior PLC released its financial results for Q3 2024, ending September 30. Further details on performance were not provided in the excerpt.

Why It Matters - Indivior's financial results can impact stock performance, indicating growth or decline, influencing investor sentiment and potential investment decisions.

News Image

Thu, 24 Oct 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - Indivior PLC reported Q3 earnings of $0.54 per share, exceeding the Zacks estimate of $0.39 and up from $0.34 per share year-over-year.

Why It Matters - Indivior's earnings beat estimates, indicating strong performance and growth, which could boost investor confidence and positively impact stock value.

...

INDV Frequently asked questions

The highest forecasted price for INDV is $16 from Chase Knickerbocker at Craig-Hallum.

The lowest forecasted price for INDV is $16 from Chase Knickerbocker from Craig-Hallum

The INDV analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.